FDA warns of an increased risk of Guillain-Barré Syndrome following vaccination with the J&J vaccine
The Food and Drug Administration today revised the Janssen COVID-19 vaccine fact sheet for healthcare providers to include a warning of an observed increased risk of Guillain-Barré Syndrome following ...
Researchers from the University of Liverpool's Centre for Drug Safety Science have identified unpredicted T-cell immune responses to the adenoviral (Oxford/AstraZeneca and Janssen) COVID-19 vaccines, ...
Researchers from the University of Liverpool’s Centre for Drug Safety Science have identified unpredicted T-cell immune responses to the adenoviral (Oxford/AstraZeneca and Janssen) COVID-19 vaccines, ...
*WASHINGTON — The coronavirus vaccine maker Johnson & Johnson was warned by the US Food and Drug Administration (FDA) on July 12 of possible rare neurological complications caused due to its dose. The ...
Johnson & Johnson's Covid-19 single-shot vaccine was shown to be 66% effective in preventing moderate and severe disease in a global Phase 3 trial, but 85% efficacy against severe disease, the company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results